SCHEMBL6798291

SCHEMBL6798291

CCC[C@@H](OCOCC)c1cc(Cl)ccc1CCC(=O)OCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.39
CYP4A11 Q02928 2/20 0.39
LMNA P02545 2/20 0.35
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.35
RAB9A P51151 1/20 0.35
MEN1 O00255 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CCKBR P32239 1/20 0.33
MC4R P32245 1/20 0.33
PPARG P37231 2/20 0.33
PPARA Q07869 2/20 0.33
P2RX3 P56373 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10164961 0.91 CYP4F2 (0.39) CYP4F2CYP4A11LMNANPC1POLB
SCHEMBL12203881 0.91 CYP4F2 (0.40) CYP4F2CYP4A11LMNANPC1POLB
SCHEMBL6744520 0.83 CYP4F2 (0.36) CYP4F2CYP4A11POLBALDH1A1GAA
SCHEMBL13263963 0.82 CYP4F2 (0.40) CYP4F2CYP4A11LMNANPC1POLB
SCHEMBL12202099 0.78 CYP4F2 (0.40) CYP4F2CYP4A11LMNANPC1TSHR
SCHEMBL6745211 0.74 CYP4F2 (0.36) CYP4F2CYP4A11POLBTSHRALDH1A1
SCHEMBL13265178 0.74 CYP4F2 (0.36) CYP4F2CYP4A11POLBTSHRALDH1A1
SCHEMBL10151162 0.74 CYP4F2 (0.37) CYP4F2CYP4A11MEN1HPGDKMT2A
SCHEMBL6745521 0.74 CYP4F2 (0.37) CYP4F2CYP4A11MEN1HPGDKMT2A
SCHEMBL901696 0.73 CYP4F2 (0.53) CYP4F2CYP4A11LMNANPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183272-B2 Indanyl compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-22 US disclosed
US-20110319359-A1 INDANYL COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319359-A1 INDANYL COMPOUNDS RYR2, ORAI1, CASR CYP4F2 868/4885CYP4A11 403/4885LMNA 2734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.